Meeder Asset Management Inc Curis Inc Transaction History

Meeder Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 17, 2019	SELL	$0.62 - $2.25 $3,340 - $12,123	-5,388 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$1.38 - $1.94 $6,746 - $9,484	4,889 Added 979.76%	5,388 $0
Q2 2018 Jul 24, 2018	BUY	$1.73 - $3.35 $863 - $1,671	499 New	499 $0

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.